首页> 美国卫生研究院文献>Frontiers in Pediatrics >Results of Treatment of Grades IV and V Vesicoureteral Reflux with Endoscopic Injection of Polyacrylate Polyalcohol Copolymer
【2h】

Results of Treatment of Grades IV and V Vesicoureteral Reflux with Endoscopic Injection of Polyacrylate Polyalcohol Copolymer

机译:内镜下注射聚丙烯酸酯多元醇共聚物治疗Ⅳ级和Ⅴ级膀胱输尿管返流的结果

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Purpose: Here we report the results of a review of a prospectively maintained database of the use polyacrylate polyalcohol copolymer (PPC) injection to correct grades IV and V VUR.>Materials and Methods: All children with grades IV and V primary VUR that presented with febrile urinary tract infection while on prophylaxis, in a 3-year period, were treated with a sub-ureteral injection of PPC. Institutional ethical approval was obtained. Exclusion criteria were incomplete bladder emptying documented on videourodynamic study, ureteral duplication, paraureteral diverticula, and poor ureteral emptying observed during fluoroscopy and previous open surgical or endoscopic treatment. Pre- and post-operative evaluation included urinalysis, renal and bladder ultrasonography, DMSA scan, and videourodynamic studies.>Results: Thirty-three children [36 renal units (RU)] were included with a median age of 57 months (range 7–108). There were 18 boys and 15 girls. Thirty RU had grade IV and 6 grade V VUR. Median follow-up time was 32 months (range 7–58). Reflux was cured in 32/36 RU with the first injection, but another two patients were reimplanted because of dilatation. Complications included early urinary tract infection in seven children, transient lower urinary tract symptoms in five children. Progressive ureteral dilatation was noted in four children and was treated with insertion of a double J stent. Two of these children eventually required an ureteroneocystostomy.>Conclusion: The use of PPC to treat grades IV and V vesicoureteral reflux in young children has an overall success rate of 83.3%. Persistent ureteral dilatation was present in 11% associated with high injection volume. Future studies will attempt to maintain a high success rate reducing the volume of injection and the incidence of dilatation.
机译:>目的:在这里,我们报告了对使用聚丙烯酸酯多元醇共聚物(PPC)注射液校正IV级和V VUR级的前瞻性数据库的审查结果。>材料和方法:对所有IV级和V级原发性VUR的儿童,在三年内预防期间出现高热性尿路感染,均接受了输尿管下注射PPC治疗。获得了机构伦理上的认可。排除标准为在视频尿动力学研究中记录的膀胱排空不全,输尿管重复,输尿管旁憩室以及在透视检查和先前开放式外科手术或内窥镜治疗期间观察到的输尿管排空不良。术前和术后评估包括尿液分析,肾和膀胱超声检查,DMSA扫描以及视频尿动力学研究。>结果:纳入了33名儿童(36个肾单位(RU)),中位年龄为57个月(范围7–108)。有18个男孩和15个女孩。 30个RU具有IV级和6级V VUR。中位随访时间为32个月(范围7-58)。第一次注射时反流在32/36 RU中治愈,但是由于扩张而将另外两名患者再植入。并发症包括7名儿童的早期尿路感染,5名儿童的暂时性下尿路症状。在四名儿童中发现进行性输尿管扩张,并通过插入双J支架进行治疗。这些孩子中的两个最终需要进行输尿管膀胱造口术。>结论:使用PPC治疗年幼的IV级和V级膀胱输尿管反流的总成功率为83.3%。持续的输尿管扩张占11%,与高注射量有关。未来的研究将试图保持较高的成功率,从而减少注射量和扩张的发生率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号